106 related articles for article (PubMed ID: 8287401)
1. Transadventitial localisation of atheromatous plaques by fluorescence emission spectrum analysis of mono-L-aspartyl chlorin e6.
Hayashi J; Kuroiwa Y; Sato H; Saito T; Aizawa K
Cardiovasc Res; 1993 Nov; 27(11):1943-7. PubMed ID: 8287401
[TBL] [Abstract][Full Text] [Related]
2. Localization of experimental submucosal esophageal tumor in rabbits by using mono-L-aspartyl chlorin e6 and long-wavelength photodynamic excitation.
Sheyhedin I; Okunaka T; Kato H; Yamamoto Y; Sakaniwa N; Konaka C; Aizawa K
Lasers Surg Med; 2000; 26(1):83-9. PubMed ID: 10637007
[TBL] [Abstract][Full Text] [Related]
3. Phase-resolved fluorescence study of mono-L-aspartyl chlorin E6.
Li L; Kodama K; Saito K; Aizawa K
J Photochem Photobiol B; 2002 May; 67(1):51-6. PubMed ID: 12007467
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic diagnosis and treatment for atherosclerosis by an endoscopic approach.
Hayashi J; Saito T; Aizawa K
Diagn Ther Endosc; 1999; 5(3):191-5. PubMed ID: 18493502
[TBL] [Abstract][Full Text] [Related]
5. In vitro photodynamic diagnosis of atherosclerotic wall changes with the use of mono-l-aspartyl chlorin e6. A preliminary report.
Biały D; Derkacz A; Wawrzyńska M; Bednarkiewicz A; Ziółkowski P; Nowosad H; Strek W
Kardiol Pol; 2003 Oct; 59(10):293-301. PubMed ID: 14618213
[TBL] [Abstract][Full Text] [Related]
6. Change in chemical composition of lipids accumulated in atheromas of rabbits following photodynamic therapy.
Hayashi J; Saito T; Aizawa K
Lasers Surg Med; 1997; 21(3):287-93. PubMed ID: 9291086
[TBL] [Abstract][Full Text] [Related]
7. Direct visualization of atherosclerosis in small coronary arteries using the epifluorescence stereoscope.
Hayashi J; Saito T; Sato H; Kuroiwa Y; Aizawa K
Cardiovasc Res; 1995 Nov; 30(5):775-80. PubMed ID: 8595626
[TBL] [Abstract][Full Text] [Related]
8. Intraocular biodistribution of mono-L-aspartyl chlorin e6 in a primate choroidal neovascularization model.
Mori K; Kanai K; Peyman GA; Yoneya S
Ophthalmic Surg Lasers Imaging; 2007; 38(2):142-7. PubMed ID: 17396695
[TBL] [Abstract][Full Text] [Related]
9. [Potential of photodynamic therapy with a second-generation sensitizer: mono-L-aspartyl chlorin e6].
Mori K; Ohta M; Sano A; Yoneya S; Sonoda M; Kaneda A; Sato Y
Nippon Ganka Gakkai Zasshi; 1997 Feb; 101(2):134-40. PubMed ID: 9124093
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of intestinal tumors with mono-L-aspartyl chlorin e6 (NPe6): a basic study.
Kikuchi T; Asakura T; Aihara H; Shiraki M; Takagi S; Kinouchi Y; Aizawa K; Shimosegawa T
Anticancer Res; 2003; 23(6C):4897-900. PubMed ID: 14981942
[TBL] [Abstract][Full Text] [Related]
11. Pilot study of topical delivery of mono-L-aspartyl chlorin e6 (NPe6): implication of topical NPe6-photodynamic therapy.
Wong TW; Aizawa K; Sheyhedin I; Wushur C; Kato H
J Pharmacol Sci; 2003 Oct; 93(2):136-42. PubMed ID: 14578580
[TBL] [Abstract][Full Text] [Related]
12. Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries.
Nagae T; Aizawa K; Uchimura N; Tani D; Abe M; Fujishima K; Wilson SE; Ishimaru S
Lasers Surg Med; 2001; 28(4):381-8. PubMed ID: 11344521
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence spectroscopic and histochemical analysis using hematoporphyrin as a microenvironmental probe for atherosclerotic change in the human aorta.
Machida M; Kameyama K; Asano G; Kumazaki T
Lab Invest; 1999 Jun; 79(6):733-45. PubMed ID: 10378516
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence properties of a hydrophilic sensitizer in pigmented rats, rabbits, and monkeys.
Moshfeghi D; Peyman GA; Kazi AA; Unal M; Khoobehi B; Yoneya S; Mori K
Ophthalmic Surg Lasers; 1999; 30(9):750-3. PubMed ID: 10574497
[TBL] [Abstract][Full Text] [Related]
15. The effects of serum on cellular uptake and phototoxicity of mono-L-aspartyl chlorin e6 (NPe6) in vitro.
Sheyhedin I; Aizawa K; Araake M; Kumasaka H; Okunaka T; Kato H
Photochem Photobiol; 1998 Jul; 68(1):110-4. PubMed ID: 9679456
[TBL] [Abstract][Full Text] [Related]
16. Photofrin II uptake by atheroma in atherosclerotic rabbits. Fluorescence and high performance liquid chromatographic analysis on post-mortem aorta.
Vever-Bizet C; L'Epine Y; Delettre E; Dellinger M; Peronneau P; Gaux JC; Brault D
Photochem Photobiol; 1989 Jun; 49(6):731-7. PubMed ID: 2528156
[TBL] [Abstract][Full Text] [Related]
17. Discrimination of normal and atherosclerotic aorta by laser-induced fluorescence.
Deckelbaum LI; Lam JK; Cabin HS; Clubb KS; Long MB
Lasers Surg Med; 1987; 7(4):330-5. PubMed ID: 3683063
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
Chan AL; Juarez M; Allen R; Volz W; Albertson T
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):72-8. PubMed ID: 15752124
[TBL] [Abstract][Full Text] [Related]
19. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model.
Wong Kee Song LM; Wang KK; Zinsmeister AR
Cancer; 1998 Jan; 82(2):421-7. PubMed ID: 9445202
[TBL] [Abstract][Full Text] [Related]
20. Photoangioplasty with local motexafin lutetium delivery reduces macrophages in a rabbit post-balloon injury model.
Hayase M; Woodbum KW; Perlroth J; Miller RA; Baumgardner W; Yock PG; Yeung A
Cardiovasc Res; 2001 Feb; 49(2):449-55. PubMed ID: 11164855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
